Market Overview

Tardive Dyskinesia | A Drug Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest analysis report on drug pipeline
for tardive
. The report includes a detailed analysis of the
pipeline molecules under investigation within the defined data
collection period to treat tardive dyskinesia.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for tardive dyskinesia, includ ...

Technavio has published a new report on the drug development pipeline for tardive dyskinesia, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Tardive dyskinesia: Market overview

Tardive dyskinesia is a socially stigmatizing long-term side effect,
which may occur with certain antipsychotic medications that are
generally prescribed for conditions such as schizophrenia and
schizoaffective disorder.

According to a senior market research analyst at Technavio, "Tardive
dyskinesia syndrome is characterized by repetitive, involuntary, and
jerking movements in the face, neck, and tongue. The symptoms of tardive
dyskinesia can be very troubling for patients and family members. The
muscle movements of the patient, especially in the face, neck, and
tongue get out of control."

Tardive dyskinesia: Segmentation analysis

This pipeline analysis report segments the tardive dyskinesia market
based on therapies employed (monotherapy), RoA (oral), therapeutic
modality (small molecule), targets (VMAT2, dopamine receptor, and
purinergic P2 receptor), MoA (VMAT2 inhibitor, dopamine receptor
agonist, and purinergic P2 receptor antagonist), geographical
segmentation (Czech Republic, Germany, Hungary, Japan, Poland, Slovakia,
and the US) and recruitment status (active, not recruiting, and
recruiting). It provides an in-depth analysis of the prominent factors
influencing the market, including drivers, opportunities, trends, and
industry-specific challenges.

Based on the mechanism of action, around 50% of the molecules that are
being investigated for the treatment of tardive dyskinesia are VMAT2

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!